Slate Run Pharmaceuticals FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Dec 5, 2024
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 3 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Slate Run Pharmaceuticals has 3 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Slate Run Pharmaceuticals" is on file.

What these totals cover: FDA records filed under the name "Slate Run Pharmaceuticals".

Latest recall
D-0343-2026 · Class III · Feb 12, 2026
Latest inspection
Dec 5, 2024 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls3Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Slate Run Pharmaceuticals's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Slate Run Pharmaceuticals: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600010
202500020
202410000
202300000
202200000
202100000
202000000
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Slate Run Pharmaceuticals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Slate Run Pharmaceuticals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

3 recall records from Mar 7, 2025 to Feb 12, 2026.

NumberClassProductDate
D-0343-2026Class IIIEptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose…Feb 12, 2026
D-0279-2025Class IICinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC…Mar 7, 2025
D-0278-2025Class IICinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC…Mar 7, 2025

Recent FDA inspections

1 inspection on Dec 5, 2024.

DateSiteProductClassificationFEI
Dec 5, 2024Columbus, OHDrugsNo Action Indicated (NAI)3012729077
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3012729077Columbus, OH1Dec 5, 2024

Slate Run Pharmaceuticals and the FDA: common questions

Has Slate Run Pharmaceuticals received an FDA warning letter?

No FDA warning letter addressed to the name "Slate Run Pharmaceuticals" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Slate Run Pharmaceuticals received an FDA Form 483?

FDA has not published a Form 483 for "Slate Run Pharmaceuticals" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Slate Run Pharmaceuticals?

The most recent FDA inspection on file ended Dec 5, 2024 at Columbus, OH and was classified NAI. FDA has 1 inspection of Slate Run Pharmaceuticals on file.

Has Slate Run Pharmaceuticals had an FDA recall?

Yes. Slate Run Pharmaceuticals has 3 FDA recalls on record. The most recent started Feb 12, 2026.

Need more than this page shows? Ask about Slate Run Pharmaceuticals in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.